Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang

Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang

Background. Transcranial sonography (TCS) is a noninvasive test that can reveal structural changes in the substantia nigra (SN) in Parkinson’s disease (PD). The purpose of this study was to investigate the relationship between SN signatures and clinical features in PD patients in a multiethnic regio...

Full description

Bibliographic Details
Main Authors:	Rurui Wei, Yan Zhang, Peishan Li, Zeheng Xu, La Zhang, Yan He, Qinfen Wu, Youcai Shi, Yang Yuan, Abudula Aisha
Format:	Article
Language:	English
Published:	Hindawi Limited 2023-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2023/8867546

Similar Items

Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
by: Shu-yang Yu, et al.
Published: (2018-01-01)

Ninetieth Anniversary of Parkinson’s Disease «Substantia Nigra» Theory
by: O.N. Voskresenskaya, et al.
Published: (2009-06-01)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
by: Lei Liu, et al.
Published: (2023-09-01)

Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI
by: Seyed-Ahmad Ahmadi, et al.
Published: (2020-01-01)

Proteome analysis of human substantia nigra in Parkinson's disease
by: Werner Cornelius J, et al.
Published: (2008-02-01)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
by: Paola Feraco, et al.
Published: (2021-06-01)

Transcranial sonography depicts a larger substantia nigra echogenic area in renal transplant patients on calcineurin inhibitors than on rapamycin
by: Nordeval Cavalcante Araújo, et al.
Published: (2022-03-01)

Clinical Features in Parkinson’s Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study
by: Zhu S, et al.
Published: (2022-08-01)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
by: Sayyed Shahid Hussain, et al.
Published: (2023-08-01)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
by: Conant Stephanie B, et al.
Published: (2006-10-01)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
by: Christian Dölle, et al.
Published: (2016-11-01)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
by: Hai-Yan Zhou, et al.
Published: (2018-07-01)

Application value of multiparametric MRI for evaluating iron deposition in the substantia nigra in Parkinson's disease
by: Qing Cao, et al.
Published: (2023-01-01)

Substantia Nigra Radiomics Feature Extraction of Parkinson’s Disease Based on Magnitude Images of Susceptibility-Weighted Imaging
by: Qingguo Ren, et al.
Published: (2021-05-01)

Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
by: Dhairya A. Lakhani, et al.
Published: (2024-01-01)

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease
by: Renee M. Miller, et al.
Published: (2006-02-01)

Radiomic Features of the Nigrosome-1 Region of the Substantia Nigra: Using Quantitative Susceptibility Mapping to Assist the Diagnosis of Idiopathic Parkinson's Disease
by: Zenghui Cheng, et al.
Published: (2019-07-01)

Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia
by: Zhi-Fen Dong, et al.
Published: (2017-01-01)

Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson’s disease and essential tremor
by: Xinhui Wang, et al.
Published: (2023-01-01)

Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease.
by: Menke, R, et al.
Published: (2010)

Connectivity-based segmentation of the substantia Nigra in human and its implications in Parkinson's disease.
by: Menke, R, et al.
Published: (2010)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
by: Helena Xicoy, et al.
Published: (2020-08-01)

Neuroprotective Effect of Ghrelin on Substantia Nigra in Parkinson Disease Model Induced -MPTP
by: Neda Nikoklam Nazif
Published: (2019-10-01)

Diagnostic value of combined assessment of olfaction and substantia nigra hyperechogenicity for Parkinson's disease
by: N. López Hernández, et al.
Published: (2015-10-01)

Irisin protect the Dopaminergic neurons of the Substantia nigra in the rat model of Parkinson’s disease
by: Sam Zarbakhsh, et al.
Published: (2019-07-01)

Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease
by: Bart de Laat, et al.
Published: (2024-02-01)

Regional High Iron in the Substantia Nigra Differentiates Parkinson’s Disease Patients From Healthy Controls
by: Kiarash Ghassaban, et al.
Published: (2019-05-01)

Efficacy of modified EDAS combined with a superficial temporal fascia attachment-dural reversal surgery for the precise treatment of ischemic cerebrovascular disease
by: Hanati Nuerlanbieke, et al.
Published: (2023-03-01)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
by: Yu Yuan, et al.
Published: (2023-10-01)

Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson’s disease
by: Rezzak Yilmaz, et al.
Published: (2016-11-01)

Anti-apoptotic effect of Shudipingchan granule in the substantia nigra of rat models of Parkinson′s disease
by: Qing Ye, et al.
Published: (2016-01-01)

The Effects of Enriched Environment on Substantia nigra Tissue in Parkinson’s Disease Rats with Prenatal Stress
by: Toraj Mohammad zamani, et al.
Published: (2019-01-01)

Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra
by: Maxime Assous, et al.
Published: (2014-05-01)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
by: Jay S Schneider
Published: (2018-01-01)

Magnetic resonance spectroscopy imaging of medulla oblongata and substantia nigra in idiopathic Parkinson's disease
by: Netra Rana
Published: (2013-06-01)

Echogenicity and size of substantia nigra on transcranial sonography (TCS) in patients with attention-deficit/hyperactivity disorder and healthy children aged 6–12 years: a comparative study
by: Zahra Sepehrmanesh, et al.
Published: (2023-01-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study.
by: Menke, R, et al.
Published: (2009)

Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
by: Vandana Zaman, et al.
Published: (2022-11-01)

Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
by: Shangpei Wang, et al.
Published: (2023-02-01)